SCHEMBL4987808

SCHEMBL4987808

CCC(CC(C)CC1CCC1)C(N)CC(=O)O

nearest known ligand 0.36

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
REN P00797 1/20 0.36
METAP2 P50579 2/20 0.33
ANPEP P15144 2/20 0.32
ENPEP Q07075 1/20 0.32
CPB2 Q96IY4 1/20 0.32
SLC1A3 P43003 1/20 0.31
SLC1A2 P43004 1/20 0.31
SLC1A1 P43005 1/20 0.31
BHMT Q93088 1/20 0.31
ATM Q13315 1/20 0.31
LTA4H P09960 1/20 0.31
ALDH1A1 P00352 1/20 0.30
METAP1 P53582 1/20 0.30
MMP2 P08253 1/20 0.30
MMP9 P14780 1/20 0.30
MMP12 P39900 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4993384 0.97 REN (0.38) RENMETAP2ANPEPENPEPCPB2
SCHEMBL4987374 0.96 REN (0.40) RENMETAP2CPB2ATMLTA4H
SCHEMBL4981462 0.94 ANPEP (0.36) RENANPEPENPEPBHMT
SCHEMBL4987911 0.86 METAP2 (0.36) RENMETAP2ANPEPENPEPSLC1A3
SCHEMBL4989753 0.86 METAP2 (0.37) RENMETAP2SLC1A3SLC1A2SLC1A1
SCHEMBL4988209 0.84 REN (0.35) RENMETAP2ANPEPENPEPSLC1A3
SCHEMBL4984122 0.83 METAP2 (0.39) RENMETAP2SLC1A3SLC1A2SLC1A1
SCHEMBL4989377 0.83 METAP2 (0.39) RENMETAP2ANPEPENPEPSLC1A3
SCHEMBL4989904 0.82 METAP2 (0.41) RENMETAP2BHMTALDH1A1METAP1
SCHEMBL4986842 0.82 METAP2 (0.41) RENMETAP2SLC1A3SLC1A2SLC1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1886363-A Amino acids with affinity for the alpha2delta-protein WARNER LAMBERT CO (US) 2006-12-27 CN claimed
US-20050124668-A1 Amino acids with affinity for the alpha2delta-protein WARNER-LAMBERT COMPANY LLC 2005-06-09 US claimed
US-7388023-B2 Amino acids with affinity for the α2δ-protein WARNER-LAMBERT COMPANY LLC (US) 2008-06-17 US disclosed
US-20070129550-A1 AMINO ACIDS WITH AFFINITY FOR THE ALPHA-2-DELTA-PROTEIN WANER-LAMBERT COMPANY LLC (US) 2007-06-07 US disclosed
US-7179934-B2 Amino acids with affinity for the α2δ-protein WARNER-LAMBERT COMPANY LLC (US) 2007-02-20 US disclosed
CN-1886363-A Amino acids with affinity for the alpha2delta-protein WARNER LAMBERT CO (US) 2006-12-27 CN disclosed
US-20050124668-A1 Amino acids with affinity for the alpha2delta-protein WARNER-LAMBERT COMPANY LLC 2005-06-09 US disclosed
US-20050101643-A1 Amino acids with affinity for the alpha2delta-protein WARNER-LAMBERT COMPANY LLC 2005-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050124668-A1 Amino acids with affinity for the alpha2delta-protein SCN2A, SCN1A, OPRD1 REN 3028/4885METAP2 1352/4885ANPEP 750/4885
US-20070129550-A1 AMINO ACIDS WITH AFFINITY FOR THE ALPHA-2-DELTA-PROTEIN SCN2A, OPRD1, SCN1A REN 2682/4885METAP2 1042/4885ANPEP 691/4885
US-20050101643-A1 Amino acids with affinity for the alpha2delta-protein SCN2A, OPRD1, SCN1A REN 2912/4885METAP2 1060/4885ANPEP 644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.